Added to YB: 2025-12-01
Pitch date: 2025-11-28
LOVE.V [neutral]
Cannara Biotech Inc.
+6.51%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivative products in Canada.
Market Cap
CAD 164.2M
Pitch Price
CAD 1.69
Price Target
N/A
Dividend
N/A
EV/EBITDA
6.75
P/E
12.36
EV/Sales
1.79
Sector
Personal Care Products
Category
growth
Show full summary:
Cannara Biotech FY2025 Recap
LOVE.V (earnings): 41% YoY retail sales growth, 31% national market share growth, 60% gross profit growth, 120% operating income growth. Trading 15x EV/NI, 7x EV/EBITDA on TTM basis. Delayed full 100k kg capacity to 2030 vs 2029, now targeting 88k kg (24% cut). Positive on continued holding.
Read full article (7 min)